Free Trial

DIAGNOS (DGNOF) Earnings Date, Estimates & Call Transcripts

DIAGNOS logo
$0.18 0.00 (-0.82%)
As of 05/2/2025 10:48 AM Eastern

DIAGNOS Earnings Summary

Upcoming Q4
Earnings Date
Jul. 15Estimated
Actual EPS
(Feb. 12)
-$0.01 Missed By -$0.01

DIAGNOS released Q3 2025 earnings on February 12, 2025, reporting an EPS of -$0.01. DIAGNOS currently has a trailing EPS of -$0.04

Q3 2025 Earnings Resources

DGNOF Upcoming Earnings

DIAGNOS's next earnings date is estimated for Tuesday, July 15, 2025, based on past reporting schedules.

Get DIAGNOS Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on DIAGNOS and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

DGNOF Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DGNOF Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

DIAGNOS Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
7/15/2025
(Estimated)
--------
2/12/2025Q3 2025--$0.01 -$0.01-$0.01--
11/21/2024Q2 2025--$0.01 -$0.01-$0.01--
8/21/2024Q1 2025--$0.01 -$0.01-$0.01-$0.03M
7/17/2024Q4 2024--$0.01 -$0.01-$0.01-$0.03M
2/28/2024Q3 2024--$0.01 -$0.01-$0.01-$0.04M
11/28/2023Q2 2024--$0.01 -$0.01-$0.01-$0.02M
8/24/2023Q1 2024--$0.01 -$0.01-$0.01-$0.03M
7/13/2023Q4 2023--$0.01 -$0.01-$0.01-$0.05M


This page (OTCMKTS:DGNOF) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners